Work supported by grants from the Institut de Recherches Internationales Servier, the Fondo de Investigación Sanitaria (grant 98/0697), and the CICYT (grant SAF96-0336). We acknowledge the skillful technical assistance of Leticia Campa. Thanks are given to the pharmaceutical companies for their kind supply of drugs.

  • 1
    Adell A. & Artigas F. (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study.Naunyn Schmiedebergs Arch. Pharmacol. 343,237244.
  • 2
    Adell A., Carceller A., Artigas F. (1993) In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat : effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J. Neurochem. 60,16731681.
  • 3
    Adell A., Casanovas J.M., Artigas F. (1997) Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas.Neuropharmacology 36,735741.DOI: 10.1016/S0028-3908(97)00048-8
  • 4
    Albert P.R., Zhou Q.Y., Van Tol H.H.M., Bunzow J.R., Civelli O. (1990) Cloning, functional expression and messenger RNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene.J. Biol. Chem. 265,58255832.
  • 5
    Albert P.R., Lembo P., Storring J.M., Charest A., Saucier C. (1996) The 5-HT1A receptor : signaling, desensitization, and gene transcription.Neuropsychopharmacology 14,1925.
  • 6
    Andrade R., Malenka R.C., Nicoll R.A. (1986) A G protein couples serotonin and GABAB receptors to the same channel in hippocampus.Science 234,12611265.
  • 7
    Artigas F., Romero L., De Montigny C., Blier P. (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.Trends Neurosci. 19,378383.
  • 8
    Barker E.L. & Sanders-Bush E. (1993) 5-Hydroxytrypamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.Mol. Pharmacol. 44,725730.
  • 9
    Barrett J.E., Gamble E.H., Zhang L., Guardiola-Lemaitre B. (1994) Anticonflict and discriminative stimulus effects in the pigeon of a new methoxy-chroman 5-HT(1A) agonist, (+)S 20244 and its enantiomers (+)S 20499 and (-)S 20500.Psychopharmacology (Berl.) 116,7378.
  • 10
    Bianchi G., Caccia S., Della Vedova F., Garattini S. (1988) The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).Eur. J. Pharmacol. 151,365371.
  • 11
    Blier P. & De Montigny C. (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone : electrophysiological studies in the rat brain.Synapse 1,470480.
  • 12
    Blier P. & De Montigny C. (1994) Current advances and trends in the treatment of depression.Trends Pharmacol. Sci. 15,220226.
  • 13
    Bohmaker K., Eison A.S., Yocca F.D., Meller E. (1993) Comparative effects of chronic 8-OH-DPAT, gepirone and its ipsapirone treatment on the sensitivity of somatodendritic 5-HT1A autoreceptors.Neuropharmacology 32,527534.
  • 14
    Casanovas J.M. & Artigas F. (1996) Differential effects of ipsapirone on 5-HT release in the dorsal and median raphe neuronal pathways.J. Neurochem. 67,19451952.
  • 15
    Casanovas J.M., Lésourd M., Artigas F. (1997) The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.Br. J. Pharmacol. 122,733741.
  • 16
    Clarke W.P., Yocca F.D., Maayani S. (1996) Lack of 5-hydroxytryptamine (1A)-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats.J. Pharmacol. Exp. Ther. 277,12591266.
  • 17
    Collins S., Caron M.G., Lefkowitz R.L. (1991) Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression.Annu. Rev. Physiol. 53,497508.
  • 18
    Cox R.F., Meller E., Waszczak B.L. (1993) Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT(1A) agonists.Synapse 14,297304.
  • 19
    De Vivo M. & Maayani S. (1986) Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.J. Pharmacol. Exp. Ther. 238,248253.
  • 20
    De Vry J. (1995) 5-HT1A receptor agonists : recent developments and controversial issues.Psychopharmacology (Berl.) 121,126.
  • 21
    Dugast C., Soulière F., Schmitt P., Casanovas J.M., Fattaccini C.M., Mocaër E., Lésourd M., Renaud B., Artigas F., Hamon M., Chouvet G. (1998) Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain ?Eur. J. Pharmacol. 350,171180.
  • 22
    Fanelli R.J. & McMonagle-Strucko K. (1992) Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.Synapse 12,7581.
  • 23
    Hjorth S. & Auerbach S.B. (1994) Lack of 5-HT(1A) autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis.Neuropharmacology 33,331334.
  • 24
    Hutson P.H., Dourish C.T., Curzon G. (1986) Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors.Eur. J. Pharmacol. 129,347352.
  • 25
    Invernizzi R., Bramante M., Samanin R. (1995) Extracellular concentrations of serotonin in the dorsal hippocampus after acute and chronic treatment with citalopram.Brain Res. 696,6266.
  • 26
    Kidd E.J., Hajdahmane S., Jolas T., Lanfumey L., Fattaccini C.M., Guardiola-Lemaitre B., Gozlan H., Hamon M. (1993) New methoxy-chroman derivatives, 4(N-(5-methoxy-chroman-3-yl) N-propylamino)butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)S 20244] and its enantiomers, (+)S 20499 and (-)S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.J. Pharmacol. Exp. Ther. 264,863872.
  • 27
    Kreiss D.S. & Lucki I. (1992) Densensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT.Neuropharmacology 31,10731076.
  • 28
    Kreiss D.S. & Lucki I. (1997) Chronic administration of the 5-HT1A receptor agonist 8-OH-DPAT differentially desensitizes 5-HT1A autoreceptors of the dorsal and median raphe nucleus.Synapse 25,107116.
  • 29
    Meller E., Goldstein M., Bohmaker K. (1990) Receptor reserve for 5-hydroxytryptamine-mediated inhibition of serotonin synthesis : a possible relationship to anxiolytic properties of 5-hydroxytryptamine agonists.Mol. Pharmacol. 37,231237.
  • 30
    Paxinos G. & Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
  • 31
    Pecknold J.C. (1994) Serotonin 5-HT1A agonists—a comparative review. CNS Drugs 2,234251.
  • 32
    Pérez V., Gilaberte I., Faries D., Alvarez E., Artigas F. (1997) Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.Lancet 349,15941597.
  • 33
    Pompeiano M., Palacios J.M., Mengod G. (1992) Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain : correlation with receptor binding.J. Neurosci. 12,440453.
  • 34
    Porsolt R.D., Lenegre A., Caignard D.H., Pfeiffer B., Mocaer E., Guardiola-Lemaitre B. (1992). Psychopharmacological profile of a new chroman derivative with 5-HT1A agonist properties S 20499 (+).Drug Dev. Res. 27,389402.
  • 35
    Radja F., Daval G., Hamon M., Vergé D. (1992) Pharmacological and physicochemical properties of pre- versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain : a quantitative autoradiographic study.J. Neurochem. 58,13381346.
  • 36
    Romero L. & Artigas F. (1997) Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway. Role of somatodendritic autoreceptors.J. Neurochem. 68,25932603.
  • 37
    Romero L., Celada P., Artigas F. (1994) Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus.Eur. J. Pharmacol. 265,103106.
  • 38
    Ruat M., Traiffort E., Leurs R., Tardivel-Lacombe J., Diaz J., Arrang J.M., Schwartz J.C. (1993) Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. USA 90,85478551.
  • 39
    Schechter L.E., Bolanos F.J., Gozlan H., Lanfumey L., Haj-Dahmane S., Laporte A.M., Fattaccini C.M., Hamon M. (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone : biochemical and electrophysiological studies.J. Pharmacol. Exp. Ther. 255,13351347.
  • 40
    Schoemaker H. & Langer S.Z. (1986) [3H]8-OH-DPAT labels the serotonin transporter in the rat striatum. Eur. J. Pharmacol. 124,371373.
  • 41
    Scott P.A., Chou J.M., Tang H., Frazer A. (1994) Differential induction of 5-HT1A mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.J. Pharmacol. Exp. Ther. 270,198208.
  • 42
    Sharp T., Bramwell S.R., Grahame-Smith D.G. (1989) 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.Br. J. Pharmacol. 96,283290.
  • 43
    Sharp T., McQuade R., Bramwell S., Hjorth S. (1993) Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.Naunyn Schmiedebergs Arch. Pharmacol. 348,339346.
  • 44
    Sprouse J.S. & Aghajanian G.K. (1986) (-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists.Eur. J. Pharmacol. 128,295298.
  • 45
    Sprouse J.S. & Aghajanian G.K. (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists : a comparative study with dorsal raphe neurons.Neuropharmacology 27,707715.
  • 46
    Welner S.A., De Montigny C., Descoches J., Desjardins P., Suranyi-Cadotte B.E. (1989) Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment.Synapse 4,347352.